EzeRx is a company specialising in the production, marketing, and distribution of non-invasive diagnostic and ancillary medical devices, both within India and internationally.

Under the terms of the agreement, Sun Pharma will acquire a 37.76% equity shareholding in EzeRx at a cost of Rs 28.69 crore, according to a stock exchange filing. This investment aligns with Sun Pharma's commitment to diversifying and strengthening its product portfolio, particularly in the field of non-invasive medical technology.

EzeRx, established on July 3, 2018, is an early-stage medical technology company with a focus on innovative non-invasive screening solutions for early detection of primary health parameters.